50% OF ALL NDAs SUPPORTED SINCE 2014

NEWS AND MEDIA

See what we’re up to – and what we have to say – in today’s dynamic market.

All NEWS/MEDIA

What’s Trending: Voice Assistants

Learn from industry experts – including ERT’s Karin Beckstrom – about how smart speakers and Voice Assistance (VA) technology are improving healthcare as well as pharma’s clinical development and commercialization processes.

Read More

Looking Forward to….

Hear from ERT’s Chief Data Officer – Prakriteswar Santikary, PhD – on how Artificial Intelligence (AI) can help clinical trial sponsors cut costs, improve data quality, and reduce trial times, helping them get new medications to market sooner.

Read More

Accelerating Development

Here we review how a Risk-Based Quality Management (RBQM) approach to trial oversight can overcome many of the challenges facing clinical trial sponsors today ─ delivering the highest quality data, study performance improvements, and significant cost savings throughout their clinical trials.

Read More








Therapeutic Innovation and Regulatory Science

Published on behalf of the ePRO Consortium, this article recommends a structured framework for training site personnel and study participants in order to optimize the advantages clinical trial sponsors can gain from using ePRO data collection systems.

Read More

Risk-based Quality Management: The New Normal

This article reviews how clinical trial sponsors who take a risk-based approach to trial planning, management, and oversight can improve data quality, protocol compliance, enrollment and retention, ultimately achieving significant clinical development cost and time savings.

Read More




Digital Technology Changing the Face of Clinical Research

This article presents the opinions of industry thought leaders – including ERT’s Chief Technology Officer, Don Ragas – on how clinical trial sponsors and CROs are leveraging technology solutions to address the clinical development challenges facing the industry today and in the future.

Read More



Assessing Cardiac Safety in Phase I

Learn how clinical trial sponsors who conduct QT assessments during Phase I can harness the power of early knowledge to better inform their development decisions while saving considerable time and money.

Read More